HIF-2α-IN-3 |
Katalog-Nr.GC62418 |
HIF-2α-IN-3, ein allosterischer Inhibitor des Hypoxie-induzierbaren Faktors-2α (HIF-2α), weist einen IC50 von 0,4 μM und einen KD von 1,1 μM auf. Antikrebsmittel.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 313964-19-1
Sample solution is provided at 25 µL, 10mM.
HIF-2α-IN-3, an allosteric inhibitor of hypoxia inducible factor-2α (HIF-2α), exhibits an IC50 of 0.4 µM and a KD of 1.1 µM. Anticancer agent[1].
HIF-2α-IN-3 (Compound 1) inhibit HIF-2α-ARNT (also known as HIF-β) heterodimerization by binding an internal cavity of the HIF-2α PAS-B domain[1].
[1]. Rogers JL, et al. Development of inhibitors of the PAS-B domain of the HIF-2α transcription factor. J Med Chem. 2013 Feb 28;56(4):1739-47.
Average Rating: 5
(Based on Reviews and 9 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *